We are live on ! Find out more
SAGE

Sage Therapeutics
SAGE

Delisted

SAGE was delisted on the 30th of July, 2025.

Back to rankings

152 hedge funds and large institutions have $1.72B invested in Sage Therapeutics in 2016 Q3 according to their latest regulatory filings, with 36 funds opening new positions, 59 increasing their positions, 41 reducing their positions, and 27 closing their positions.

New
Increased
Maintained
Reduced
Closed

89% more capital invested

Capital invested by funds: $911M → $1.72B (+$810M)

44% more repeat investments, than reductions

Existing positions increased: 59 | Existing positions reduced: 41

33% more first-time investments, than exits

New positions opened: 36 | Existing positions closed: 27

14% more call options, than puts

Call options by funds: $24.9M | Put options by funds: $21.8M

6% more funds holding

Funds holding: 144 → 152 (+8)

29% less funds holding in top 10

Funds holding in top 10: 7 → 5 (-2)

Holders
152
Holders Change
+8
Holders Change %
+5.56%
% of All Funds
4.06%
Holding in Top 10
5
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-28.57%
% of All Funds
0.13%
New
36
Increased
59
Reduced
41
Closed
27
Calls
$24.9M
Puts
$21.8M
Net Calls
+$3.06M
Net Calls Change
-$17.6M

Top Buyers

Rank Fund Capital Flow
1
O
OppenheimerFunds
New York
+$46.6M
2
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$37.9M
3
Federated Hermes
Federated Hermes
Pennsylvania
+$37.8M
4
Fidelity Investments
Fidelity Investments
Massachusetts
+$27.3M
5
Citadel Advisors
Citadel Advisors
Florida
+$25.4M

Top Sellers

Rank Fund Capital Flow
1
CAM
Cormorant Asset Management
Massachusetts
-$22M
2
EAM
Eagle Asset Management
Florida
-$9.91M
3
GGHC
Gilder Gagnon Howe & Co
New York
-$9.77M
4
Franklin Resources
Franklin Resources
California
-$8.46M
5
FHAM
Folger Hill Asset Management
New York
-$7.31M
Name Holding Trade Value Shares
Change 		Change in
Stake
JP
51
Jana Partners
New York
$5.12M +$4.52M +111,127 New
Charles Schwab
52
Charles Schwab
California
$4.9M +$1.44M +35,346 +50%
FHAM
53
Folger Hill Asset Management
New York
$4.62M -$7.31M -179,674 -64%
Invesco
54
Invesco
Georgia
$4.62M +$4.08M +100,231 New
SO
55
STRS Ohio
Ohio
$4.49M +$3.97M +97,500 New
BG
56
BlackRock Group
United Kingdom
$4.38M +$1.28M +31,517 +50%
FLAM
57
First Light Asset Management
Minnesota
$4.33M +$3.83M +94,037 New
Lazard Asset Management
58
Lazard Asset Management
New York
$3.76M +$989K +24,300 +42%
GH
59
GAM Holding
Switzerland
$3.66M -$3.23M -79,400 -50%
Ameriprise
60
Ameriprise
Minnesota
$3.48M +$707K +17,372 +30%
BAMCO Inc
61
BAMCO Inc
New York
$3.38M +$1.08M +26,455 +56%
HP
62
Harbourvest Partners
Massachusetts
$3.37M -$1.28M -31,400 -30%
NIP
63
Nicholas Investment Partners
California
$3.29M +$2.91M +71,483 New
HTC
64
Hershey Trust Company
Pennsylvania
$3.06M +$307K +7,547 +13%
CS
65
Credit Suisse
Switzerland
$3M +$1.23M +30,269 +87%
California State Teachers Retirement System (CalSTRS)
66
California State Teachers Retirement System (CalSTRS)
California
$2.94M +$338K +8,300 +15%
GC
67
Guggenheim Capital
Illinois
$2.79M +$2.46M +60,509 New
JGC
68
J. Goldman & Co
New York
$2.33M +$167K +4,100 +9%
Swiss National Bank
69
Swiss National Bank
Switzerland
$2.33M +$399K +9,800 +24%
MIM
70
Monashee Investment Management
Massachusetts
$2.3M – – –
Axa
71
Axa
France
$2.21M +$1.79K +44 +0.1%
TAM
72
Tocqueville Asset Management
New York
$2.04M +$197K +4,850 +12%
TA
73
Teachers Advisors
New York
$1.97M – – –
Bank of America
74
Bank of America
North Carolina
$1.95M -$1.02M -25,006 -37%
AA
75
ALPS Advisors
Colorado
$1.88M -$168K -4,130 -9%
1 2
3
4 5

SAGE Hedge Fund Activity: Q3 2016 in Review

152 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Sage Therapeutics (SAGE) for Q3 2016, worth a combined $1.72B — up 89% from $911M a quarter earlier.

Buyers outnumbered sellers: 36 funds opened new SAGE positions and 27 closed out — a net gain of 9 holders — while 59 added to existing stakes and 41 trimmed.

The largest buyer was OppenheimerFunds, adding an estimated $46.6M. The largest seller was Cormorant Asset Management, exiting entirely with an estimated $22M sold.

  • 152 institutional investors held Sage Therapeutics (SAGE) as of Q3 2016, up from 144 in Q2 2016.
  • Funds reported $1.72B of Sage Therapeutics stock for Q3 2016, up 89% quarter-over-quarter.
  • 36 funds opened new Sage Therapeutics positions in Q3 2016 and 27 closed out, a net change of +9 holders.
  • The largest Sage Therapeutics buyer in Q3 2016 was OppenheimerFunds, an estimated $46.6M added.
  • The largest Sage Therapeutics seller in Q3 2016 was Cormorant Asset Management, an estimated $22M sold.

Based on aggregated 13F filings for Q3 2016.